June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Interactive Ca2+ signaling in the RPE by anaphylatoxins
Author Affiliations & Notes
  • Olaf Strauss
    Experimental Ophthalmology, Virchow-Klinikum, Berlin, Germany
  • Khava Abdusalamova
    Experimental Ophthalmology, Virchow-Klinikum, Berlin, Germany
  • Christian Huber
    Experimental Ophthalmology, Virchow-Klinikum, Berlin, Germany
  • Baerbel Rohrer
    Medical University of south Carolina, Charleston, South Carolina, United States
  • Catharina Busch
    Experimental Ophthalmology, Virchow-Klinikum, Berlin, Germany
  • Footnotes
    Commercial Relationships   Olaf Strauss, None; Khava Abdusalamova , None; Christian Huber, None; Baerbel Rohrer, None; Catharina Busch, None
  • Footnotes
    Support  Werner Jacksteadt-Stiftung; BIH Clinician Scientist grant; Novartis unrestricted grant
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2277. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Olaf Strauss, Khava Abdusalamova, Christian Huber, Baerbel Rohrer, Catharina Busch; Interactive Ca2+ signaling in the RPE by anaphylatoxins. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2277.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Through the identification of genetic risk factors, it has become apparent that dysregulation of the complement system plays a role in the pathology of age-related macular degeneration (AMD). This would predict that a less efficiently controlled alternative activation pathway would in turn harm the retinal pigment epithelium (RPE). Rather than investigating the potentially harmful effects of the activity of the terminal complement complex (membrane attack complex) on the RPE, we focused here on examining the effects of the soluble anaphylatoxins C3a and C5a, products of C3 and C5 convertases.

Methods : ARPE-19 cells, human RPE cells in primary culture and freshly isolated mouse RPE cells were investigated for their expression of the anaphylatoxin receptors by means of PCR or immunohistochemistry. Second messenger activation by the anaphylatoxins C3a or C5a was studied by Ca2+ imaging techniques using fura-2 as a Ca2+-sensitive fluorescence probe.

Results : ARPE-19 cells express the anaphylatoxin receptors C3aR and C5aR1 both on mRNA and protein level. This expression pattern was confirmed in human RPE in primary culture and in freshly isolated mouse RPE cells at the mRNA level. Application of C3a or C5a individually both led by to an increase in intracellular free Ca2+; although the Ca2+ signal in response to C5a was larger in amplitude and duration compared to that elicited by C3a. The simultaneous application of C3a and C5a did not show an additive effect; the resulting response in amplitude and duration was the same as that with C5a alone. Interestingly, when C5a was applied at the moment when the C3a-induced Ca2+ response has reached its steady-state level, this led to a decrease in the Ca2+ signal. Analysis of the downstream events using blockers against protein kinases known to control anaphylatoxin-mediated signaling in T-cells revealed that the C5a-stimulated Ca2+ response depended on the activation of Akt and PI3 kinases, whereas surprisingly the C3a-evoked response was increased by inhibition of Akt kinase.

Conclusions : The RPE is able to respond to complement activation already at the level of the anaphylatoxins. Both anaphylatoxins seem to use different down-stream Ca2+ induced signaling pathways. However, combined receptor activation results in an interactive behavior that appears to be dominated by C5aR engagement. Thus the anaphylatoxin-dependent signaling in the RPE might have important impacts on the etiology of AMD.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×